Clinical Trial Update: ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating adding bismuth to standard triple therapy for Helicobacter pylori eradication has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth (bismuth)
• standard triple therapy

Snippet

Sponsor: Ziauddin University | Conditions: Helicobacter Pylori Infection | Phase 2 | Status: COMPLETED